1. Home
  2. COLM vs ADPT Comparison

COLM vs ADPT Comparison

Compare COLM & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

HOLD

Current Price

$66.46

Market Cap

3.1B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$17.53

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLM
ADPT
Founded
1938
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
COLM
ADPT
Price
$66.46
$17.53
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$62.50
$17.78
AVG Volume (30 Days)
425.0K
3.0M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.00%
N/A
EPS Growth
N/A
63.89
EPS
0.65
N/A
Revenue
$3,042,478,000.00
$276,976,000.00
Revenue This Year
$3.73
$3.98
Revenue Next Year
$3.29
$22.72
P/E Ratio
$101.46
N/A
Revenue Growth
N/A
54.77
52 Week Low
$47.48
$9.96
52 Week High
$69.06
$20.76

Technical Indicators

Market Signals
Indicator
COLM
ADPT
Relative Strength Index (RSI) 57.57 59.38
Support Level $53.13 $14.87
Resistance Level $68.10 $17.72
Average True Range (ATR) 1.95 1.37
MACD -0.17 0.02
Stochastic Oscillator 52.49 58.31

Price Performance

Historical Comparison
COLM
ADPT

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: